genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Search
About GEN
Contact GEN
Subscribe/Update Preferences
Log In
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Autoimmune Disease Drugs
Amgen to Acquire ChemoCentryx for $3.7B, Bolstering Autoimmune Portfolio
Antibodies
Monoclonal Antibody Prevents Malaria in Clinical Trial
Alzheimers
Novel Alzheimer’s Therapy without Inflammatory Side Effects
News
Muscle Regeneration May Be Boosted by Naturally Occurring Compound
Bacteriophage
Oral Combination Phage Therapy Targets IBD-Related Gut Bacteria, Spares Helpful Microbes
Insights
All
Trends for 2020
Trends for 2021
Alzheimers
Questionable Data Jeopardizes Alzheimer’s Amyloid Theory
Cancer
Left-Field Lessons in Immunity: Z-Nucleic Acids Stage a Comeback
Antibodies
Biomanufacturing Parallels the Semiconductor Chip Revolution
Bioprocessing
Altering Vector Genetics Improves Cell-free Protein Synthesis
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
A-Lists
Seven Biopharma Trends to Watch in 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
GEN Protocols
Resources
Summits
Webinars
GEN Live
eBooks/Perspectives
Podcasts
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
– INSIDE –
PRECISION MEDICINE
Home
Therapeutics
Radiopharmaceuticals
Radiopharmaceuticals
Anti-Ulcerants
Antibacterials
Antibiotics
Anticoagulants
Antidiabetics
Antifungals
Antivirals
Autoimmune Disease Drugs
Biologics
Biosimilars
Cardiovascular Drugs
Cellular Therapeutics
Combination Therapies
Dermatologic Drugs
Enzyme Replacement Therapy
Generics
Hormone Replacement Therapy
Immuno-oncology
Immunotherapies
Lipid Regulators
Mental Health Drugs
Oncologics
Orphan Drugs
Pain
Protein Therapeutics
Psychoactive Drugs
Radiopharmaceuticals
Respiratory Drugs
Traditional Chinese Medications
Vaccines
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Radiopharmaceuticals
Protein Identified That May Decrease Radiation Side Effects
Radiopharmaceuticals
Progenics Aims for 2017 Azedra NDA Following Positive Pivotal Trial Data
Radiopharmaceuticals
Gates Foundation Invests up to $40M in Immunocore to Develop TCR-Based Therapies
Radiopharmaceuticals
O Radiotherapy Resistance, Where Is Thy STING?
Radiopharmaceuticals
Endocyte Refocuses Development on Prostate Cancer Radioligand Therapeutic
Gene Therapy
StockWatch: Bluebird Surges on FDA Advice, but Only Briefly
Radiopharmaceuticals
Endocyte Refocuses Development on Prostate Cancer Radioligand Therapeutic
Scroll Up